Evidence map›Paper›PMID 34769424›Full record

ArticleInternational journal of molecular sciences2021

Identification of Spiro-Fused Pyrrolo[3,4-

Diana K Latypova, Stanislav V Shmakov, Sofya A Pechkovskaya, Alexander S Filatov, Alexander V Stepakov, Nickolay A Knyazev, Vitali M Boitsov

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Chemistry and Biological Activity of 11Molecules (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Study of Cytotoxicity of 3-Azabicyclo[3.1.0]hexanes and Cyclopropa[International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. 11International journal of molecular sciences · 2022
    Article
  9. Article
  10. Innovation through Tradition: The Current Challenges in Cancer Treatment.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Diana K LatypovaSaint-Petersburg National Research Academic University of the Russian Academy of Sciences, 194021 Saint-Petersburg, Russia.
Stanislav V ShmakovSaint-Petersburg National Research Academic University of the Russian Academy of Sciences, 194021 Saint-Petersburg, Russia.
Sofya A PechkovskayaInstitute of Cytology, Russian Academy of Sciences, 194064 Saint-Petersburg, Russia.
Alexander S FilatovDepartment of Chemistry, Saint-Petersburg State University, 199034 Saint Petersburg, Russia.
Alexander V StepakovDepartment of Chemistry, Saint-Petersburg State University, 199034 Saint Petersburg, Russia.
Nickolay A KnyazevInstitute of Cytology, Russian Academy of Sciences, 194064 Saint-Petersburg, Russia.
Vitali M BoitsovSaint-Petersburg National Research Academic University of the Russian Academy of Sciences, 194021 Saint-Petersburg, Russia.ORCID 0000-0002-4857-2046
Saint Petersburg Academic University · RUInstitute of Cytology · RUSt Petersburg University · RU

Funding

Russian Science Foundation RSF 20-15-00332
6 · The paper itself

Abstract

A series of heterocyclic compounds containing a spiro-fused pyrrolo[3,4-

Indexed as

Antineoplastic AgentsApoptosisCell CycleCell Line, TumorCell MovementCell ProliferationDrug Screening Assays, AntitumorFemaleHumansLeukemia, Erythroblastic, AcutePyrrolidinesQuinazolinesSpiro CompoundsUterine Cervical NeoplasmsAntineoplastic AgentsPyrrolidinesQuinazolinesSpiro Compoundstryptanthrine1,3-dipolar cycloadditionantiproliferative activitycell cyclecell deathcell motilitymorphological changes (cytoskeleton)one-pot synthesispyrrolo[3,4-a]pyrrolizinetryptanthrin-derived azomethine ylidetumor cells

Identifiers

PMID34769424
PMCPMC8584944
OpenAlexW3214555669

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.